The single-use fermentation solutions will enhance the company’s microbial fermentation processes and provide faster turnaround product to product and between batches
Abec, a global provider of integrated solutions and services for biopharmaceutical manufacturing and Biovectra, a CDMO specialising in clinical-to-commercial scale production of regulated biologics, APIs and intermediates, have announced Abec will design, manufacture, and install CSR single-use microbial fermentation technology at Biovectra’s manufacturing facility in Nova Scotia, Canada. A fast-track manufacturing schedule is planned to enable the facility to be operational by Q2, 2022.
The single-use fermentation solutions will enhance the company’s microbial fermentation processes and provide faster turnaround product to product and between batches. The addition of large-scale single-use fermentation capability also provides Biovectra’s customers with more flexibility, faster turnaround and higher capacity utilisation. The solutions provider is also supplying CSR single-use disposable containers from its two in-house ISO-7 cleanroom manufacturing facilities.
"Biovectra will be the first Canadian CDMO to offer single-use, microbial fermentation at 1,000L scale," said Heather Delage, CCO, Biovectra. "Abec’s 100 L and 1,000 L fermentation suites, complement our fixed asset base in biologics fermentation, bringing our customers improved economies of scale and greater process flexibility."
"Abec continues to lead the industry advancing bioprocess manufacturing with large-scale single-use process solutions," said Scott Pickering, Abec CEO and Chair. "We are excited to help Biovectra expand their capability, offering single-use, microbial fermentation at large-scale, and we look forward to supporting their continued success."